Enliven Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $72M | 3.5M | 20.47 |
| 2025-06-30 | $60M | 3.0M | 20.06 |
| 2025-03-31 | $59M | 3.0M | 19.68 |
| 2024-12-31 | $67M | 3.0M | 22.50 |
| 2024-09-30 | $75M | 2.9M | 25.54 |